Burn and Scald Medicine Comprehensive Report 2025-2031: Market Size, Volume, Growth Prospects, and Regional Analysis

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Burn and Scald Medicine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for Burn and Scald Medicine was valued at US$ 4519 million in the year 2024 and is projected to reach a revised size of US$ 6358 million by 2031, growing at a CAGR of 5.0% during the forecast period.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/3605647/burn-and-scald-medicine
According to the new market research report "Burn and Scald Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", published by QYResearch, the global Burn and Scald Medicine market size is projected to reach USD 0.6 billion by 2030, at a CAGR of 3.9% during the forecast period.
According to QYResearch Top Players Research Center, the global key manufacturers of Burn and Scald Medicine include Mebao Pharmaceutical Technology Group, B. Braun, Integra LifeSciences, Jinyao Darentang, Smith & Nephew, etc. In 2023, the global top five players had a share approximately 43.0% in terms of revenue.

According to QYResearch Top Players Research Center, the global key manufacturers of Burn and Scald Medicine include Mebao Pharmaceutical Technology Group, B. Braun, Integra LifeSciences, Jinyao Darentang, Smith & Nephew, Yangtze River Pharmaceutical Group, STADA Thornton & Ross, Kenvue Brands LLC, Changchun Overseas Pharmaceutical Group Co., Ltd., Orkla Health, etc. In 2023, the global top 10 players had a share approximately 49.0% in terms of revenue.

The increasing aging of the population has increased the proportion of burns and scalds caused by accidents such as falls and scalds among the elderly, thus driving the demand for the burn and scald drug market. The frequent occurrence of industrial accidents and the accelerated pace of life have also increased the incidence of burns and scalds, further expanding the market demand.

The continuous advancement of medical technology, especially the application of biotechnology and nanotechnology in burn treatment, has brought new development opportunities to the burn and scald drug industry.

The research and development of new drugs, such as growth factors and skin regeneration factors, have provided new treatment methods for burn and scald treatment, improved the treatment effect, and met the diverse needs of patients.

The state has issued a series of policies and regulations for the field of burn and scald drugs, aiming to regulate the market order and ensure the safety of patients' medication. These regulations provide legal protection for the burn and scald drug industry and promote the healthy development of the industry.

Policy support and supervision guide enterprises to increase R&D investment, promote the development of new drugs, promote industrial upgrading, and bring more development opportunities to the industry.

Favorable measures of the government, such as compensation policies covering almost 70-100% of treatment costs, enable patients to choose advanced burn care treatment. The presence of governmental organizations, such as the World Health Organization (WHO), and non-profit organizations, such as the American Burn Association (ABA), have also helped to raise awareness levels. WHO has been working with the International Society for Burn Injuries and other such organizations to develop strategies to improve burn care worldwide and prevent such injuries. Non-profit organizations that aim to provide and disseminate knowledge about optimal treatment and rehabilitation after burns, such as the British Burn Association and the Canadian Burn Nurses Association, are also raising awareness levels.

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The Burn and Scald Medicine market is segmented as below:
By Company
Nipro
MediWound
STADA Arzneimittel
Elastoplast
Pfizer
Bharat Biotech
Paul Hartmann
Ono Pharmaceutical
Centaur Pharmaceuticals
Kedrion Biopharma
Smith & Nephew
ConvaTec
B. Braun Melsungen
Coloplast
Mölnlycke Health Care
Medline Industries
Hartmann
Ferndale Pharmaceuticals
Guizhou Jingcheng Medicine
Mebo Pharmaceutical Technology
Shanghai Tenry Pharm
Guilin Huanuo Gene Pharmaceutical
Shanghai Haohai Biotechnology
Beijing SL Pharmaceutical
Hubei Mayinglong Pharmaceutical
Jianmin Group
Tianjin Pharm Group
Cardinal Health
Integra LifeSciences
Deroyal
DermaRite Industries

Segment by Type
Dressing
Ointment
Spray

Segment by Application
Hospital
Clinic
Pharmacy
Online

Each chapter of the report provides detailed information for readers to further understand the Burn and Scald Medicine market:
Chapter 1: Introduces the report scope of the Burn and Scald Medicine report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2020-2031)
Chapter 2: Detailed analysis of Burn and Scald Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2020-2025)
Chapter 3: Provides the analysis of various Burn and Scald Medicine market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2020-2031)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2020-2031)
Chapter 5: Sales, revenue of Burn and Scald Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2020-2031)
Chapter 6: Sales, revenue of Burn and Scald Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.(2020-2031)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2020-2025)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:
Competitive Analysis: QYResearch provides in-depth Burn and Scald Medicine competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.
Industry Analysis: QYResearch provides Burn and Scald Medicine comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.
and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.
Market Size: QYResearch provides Burn and Scald Medicine market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
Global Burn and Scald Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Burn and Scald Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting (data is widely cited in prospectuses, annual reports and presentations), industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let's work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

This release was published on openPR.